CervoMed Inc.

Last updated September 27, 2026

Organization details

Legal name
CervoMed Inc.
Former names
Diffusion Pharmaceuticals Inc. RestorGenex Corp Stratus Media Group, Inc Feris International, INC. Titan Motorcycle Co of America Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Boston
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CRVO
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001053691
EIN
30-0645032

Board of directors

Chief executives

John J. Alam · CEO & President
Since August 2023
Robert Joseph Cobuzzi Jr. · President & CEO
Until August 2023 · Former

Director election results

Annual meeting of June 23, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 2 other boards. 1 is in the same sector.

Network of CervoMed Inc.'s board connections Q32 Bio Inc. Q32 Bio Inc. Revvity Inc. Revvity Inc. Jeffrey Poulton V Jeffrey Poulton V Sylvie Gregoire Sylvie Gregoire CervoMed Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$3,737,723
19 purchases by 5 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 11, 2026 Joshua S. Boger Director, 10% owner Open-market purchase +955,414 $3.14 $3,000,000
Nov 18, 2025 Winton Matthew Officer (Chief Commercial and Business) Open-market purchase +1,500 $7.95 $11,925
Nov 18, 2025 ELDER WILLIAM ROBERT Officer (CFO, GC & Secretary) Open-market purchase +2,500 $8.32 $20,800
Nov 17, 2025 Winton Matthew Officer (Chief Commercial and Business) Open-market purchase +3,500 $8.43 $29,505
Nov 17, 2025 Sylvie Gregoire Director, 10% owner Open-market purchase +10,793 $8.46 $91,309
Nov 17, 2025 ELDER WILLIAM ROBERT Officer (CFO, GC & Secretary) Open-market purchase +1,000 $8.45 $8,450
Nov 17, 2025 John J. Alam Director, Officer (CEO & President), 10% owner Open-market purchase +10,807 $8.46 $91,427
Nov 17, 2025 Sylvie Gregoire Director, 10% owner Open-market purchase +10,807 $8.46 $91,427
Nov 17, 2025 John J. Alam Director, Officer (CEO & President), 10% owner Open-market purchase +10,793 $8.46 $91,309
Nov 14, 2025 Winton Matthew Officer (Chief Commercial and Business) Open-market purchase +10,000 $7.57 $75,700
Nov 14, 2025 Sylvie Gregoire Director, 10% owner Open-market purchase +1,707 $7.57 $12,922
Nov 14, 2025 John J. Alam Director, Officer (CEO & President), 10% owner Open-market purchase +1,693 $7.55 $12,782
Nov 14, 2025 Sylvie Gregoire Director, 10% owner Open-market purchase +1,693 $7.55 $12,782
Nov 14, 2025 John J. Alam Director, Officer (CEO & President), 10% owner Open-market purchase +1,707 $7.57 $12,922
Nov 13, 2025 Sylvie Gregoire Director, 10% owner Open-market purchase +4,447 $7.51 $33,397

Organizations in the same sector, closest in location and size first.

Questions about CervoMed Inc.

Who is the CEO of CervoMed Inc.?

John J. Alam has been CervoMed Inc.'s CEO & President since August 2023.

How many directors are on CervoMed Inc.'s board?

CervoMed Inc.'s board has 11 directors: David Quigley, Diana M. Lanchoney, Frank Zavrl, Jane H. Hollingsworth, Jeffrey Poulton V, Jill Davidson, John J. Alam, Joshua S. Boger, Marwan Sabbagh, Robert Joseph Cobuzzi Jr. and 1 other.

Are CervoMed Inc. insiders buying or selling shares?

Over the last 12 months, CervoMed Inc. insiders bought $3.7 million of shares in 19 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="cervomed-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.